-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Acer Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Acer Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$12.9M, a 146% decline year-over-year.
- Acer Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$27.4M, a 15.4% decline year-over-year.
- Acer Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$24.6M, a 54.3% decline from 2021.
- Acer Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$15.9M, a 30.1% increase from 2020.
- Acer Therapeutics Inc. annual Operating Income (Loss) for 2020 was -$22.8M, a 23.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)